Expertise in
10
conditions

Alexander Mustea

Ferdinand Sauerbruch Str, 
Greifswald, MV, DE 
Expertise in
10
conditions
Ferdinand Sauerbruch Str, 
Greifswald, MV, DE 

Overview

Alexander Mustea practices practicing medicine in Greifswald, Germany.

Mr. Mustea is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Vulvar Cancer, Ovarian Cancer, Vaginal Cancer, Lymphadenectomy, and Vulvectomy.

He is actively involved in clinical research, co-authoring 164 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Ferdinand Sauerbruch Str, Greifswald, MV 17475, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

MIRASOL: A Randomized, Open-label, Phase 3 Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression
MIRASOL: A Randomized, Open-label, Phase 3 Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression
Enrollment Status: Completed
Publish Date: August 27, 2025
Intervention Type: Drug
Study Drugs: Mirvetuximab Soravtansine, Paclitaxel, Topotecan, Pegylated liposomal doxorubicin
Study Phase: Phase 3
A Multicentre, Open-label, Three-arm Randomised Phase II Trial Assessing the Safety and Efficacy of the HSP90 Inhibitor Ganetespib in Combination With Carboplatin Followed by Maintenance Treatment With Niraparib Versus Ganetespib Plus Carboplatin Followed by Ganetespib and Niraparib Versus Carboplatin in Combination With Standard Chemotherapy Followed by Niraparib Maintenance Treatment in Platinum-sensitive Ovarian Cancer Patients
A Multicentre, Open-label, Three-arm Randomised Phase II Trial Assessing the Safety and Efficacy of the HSP90 Inhibitor Ganetespib in Combination With Carboplatin Followed by Maintenance Treatment With Niraparib Versus Ganetespib Plus Carboplatin Followed by Ganetespib and Niraparib Versus Carboplatin in Combination With Standard Chemotherapy Followed by Niraparib Maintenance Treatment in Platinum-sensitive Ovarian Cancer Patients
Enrollment Status: Completed
Publish Date: June 11, 2025
Intervention Type: Drug
Study Drugs: Ganetespib, Niraparib, Carboplatin, Paclitaxel, Gemcitabine
Study Phase: Phase 2
View 1 Less Clinical Trial

164 Total Publications

Pelvic Floor Disorders in Women with Breast Cancer and Gynaecological Cancer: Real-World Data from a Prospective Multicentre Cross-Sectional Survey.
Pelvic Floor Disorders in Women with Breast Cancer and Gynaecological Cancer: Real-World Data from a Prospective Multicentre Cross-Sectional Survey.
Journal: Journal of clinical medicine
Published: June 23, 2026

Frequently Asked Questions about Alexander Mustea

Is Alexander Mustea a top-rated expert for Vulvar Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Alexander Mustea is classified as an Elite expert for Vulvar Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Alexander Mustea participate in research or clinical trials?

Yes. Alexander Mustea has published 164 articles and abstracts on conditions like Vulvar Cancer. You can view a list of Alexander Mustea's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Mustea's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 18 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile